OBJECTIVE： To summarize general regularity and characteristics of amiodarone-induced pulmonary toxicity， and to provide reference for rational use of amiodarone and avoiding the occurrence of ADR. METHODS： Retrieved from CNKI， VIP and Wanfang database， individual case report literatures about amiodarone-induced pulmonary toxicity were collected during 1990-2016. The included cases were analyzed statistically. RESULTS： A total of 19 related literatures were collected， involving 20 cases of amiodarone-induced pulmonary toxicity. Among them， the patients older than 60 years old accounted for 75.0％ with ratio of male to female 3 ∶ 1. 75.0％ patients had used medicine more than 1 month when pulmonary toxicity occurred. The dose of amiodarone in 17 patients ranged 200-400 mg/d. Six patients died， accounting for 30.0％. CONCLUSIONS： Pulmonary toxicity induced by amiodarone may be related to patients’ gender， age， dose and medication time. The mortality of it is in relative high level. Medical staff should pay attention to it， regularly monitor and process it timely.